Webinars

MAY 25, 2023 10:00 AM PDT

Evaluating MGUS with Free Light Chain Assays in Clinical Practice

Sponsored by: Siemens Healthineers

C.E. Credits: P.A.C.E. CE ｜ Florida CE

7 +10pts

Speaker

Event Date & Time

Date: May 25, 2023

Time: 10:00 AM (PDT), 1:00 PM (EDT), 7:00 PM (CEST)

Abstract

Free light chains, kappa (κ) lambda (λ), are produced by plasma cells and known to be an important marker in patients with Multiple Myeloma and AL Amyloidosis. The precursor condition to Multiple Myeloma is called Monoclonal Gammopathy of Undetermined Significance (MGUS) and although these individuals are not immediately treated, they are closely monitored due to their risk of progression to Multiple Myeloma¹.

We invite you to join us for a new webinar with Dr. John Mitsios, PhD, as he discusses the potential clinical usage of the N-Latex FLC assay in evaluation of MGUS.

Learning Objectives

Define multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS)
Describe the clinical criteria used to define multiple myeloma
Describe the use of free light chains in the evaluation of MGUS

1. Kyle et. Al. Leukemia 2010

Webinars will be available for unlimited on-demand viewing after live event.

Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Evaluating MGUS with Free Light Chain Assays in Clinical Practice

Dr. John V. Mitsios